Business Development
Home » Business Development
Business Development

Our Business Development function is always willing to explore new business development opportunities and collaborations through forming strategic partnerships and alliances in various business models. We are certain of achieving mutual success with progressive partners who share our eagerness for growth through our niche and differentiated line of products.



We are looking for distribution partners in countries where we don’t have presence in. Please explore our global map and contact us if interested to collaborate.


  • In-Licensing: We are looking for licensing partners who can complement our product offerings with innovative high-value products while providing them with market access and a sales and marketing platform to all countries and regions we operate in.
  • Out-Licensing: We have carefully selected a comprehensive out-licensing product offering to ensure providing an added value to our partners’ commercial success. API provides a highly differentiated and highly in demand portfolio of products to choose from including Metered Dose Nasal Sprays line (CE Class I Medical Device) which is available in both spray and aerosol forms as well as Ophthalmic Eye Drops and Eye Ointments lines. Explore these Product lines further here.
  • Our value proposition to our partners:

    • Quality products with CTD and eCTD dossiers meeting all the regulatory requirements
    • Regulatory knowledge and expertise
    • Support in developing registration strategies for our partners
    • Professional and competent project management team
    • Guaranteed cost leadership
    • Our differentiator to other licensing providers:

      • Niche and focused products
      • Low production costs
      • Customized and comprehensive business offering



    We can also offer our manufacturing services and become your strategic production partner for your growth ambitions globally helping your company achieve higher levels of profitability by providing reduction in overall costs including overheads and capital investments and direct and indirect production & packaging costs combined with qualitative manufacturing in our facilities at the highest international standards.

    We are also open to exploring opportunities of establishing a greenfield manufacturing facility in countries where a large untapped market exists which makes strategic business sense.